Bruce Neal's Publications

About Bruce Neal's Publications

Senior Professorial Fellow

  • Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials

    Cancers Date published:

  • Estimating the potential impact of the Australian government’s reformulation targets on household sugar purchases

    International Journal of Behavioral Nutrition and Physical Activity Date published:

  • The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study

    PLOS Medicine Date published:

  • The Role of Sodium Glucose Cotransporter-2 Inhibitors in Atherosclerotic Cardiovascular Disease: A Narrative Review of Potential Mechanisms

    Cells Date published:

  • Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial

    Date published:

  • Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial

    European Heart Journal Date published:

  • KidneyIntelX as an Enrichment Tool for Clinical Trials in Early Diabetic Kidney Disease

    Journal of the American Society of Nephrology Date published:

  • Barriers and Facilitators to Implementing Reduced-Sodium Salts as a Population-Level Intervention: A Qualitative Study

    Nutrients Date published:

  • Effect of Salt Substitution on Cardiovascular Events and Death

    New England Journal of Medicine Date published:

  • A Systematic Review of Salt Reduction Initiatives Around the World: A Midterm Evaluation of Progress Towards the 2025 Global Non-Communicable Diseases Salt Reduction Target

    Advances in Nutrition Date published:

  • Healthy Food Prescription Programs and their Impact on Dietary Behavior and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis

    Advances in Nutrition Date published:

  • Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial

    The Lancet Date published:

  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

    The Lancet Date published:

  • Supplement Article

    European Journal of Heart Failure Date published:

  • Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program

    Diabetologia Date published:

  • Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial

    European Heart Journal Date published: